Doi M, et al
As options grow, expert, personalized care will be crucial to ensure patients receive the right treatment
Regional Variations Prevalence rates for overweight and obesity are very different in each region with the Middle East, Central and Eastern Europe and North America having higher prevalence rates
Conclusion and Future Directions Several obesogens have been identified to date, encompassing a panoply of ubiquitous compounds in everyday life activities
USA 87 , 36403644 (1990)
There is a a randomized, placebo-controlled trial, showing TVB-2640, a fatty acid synthase inhibitor, can significantly reduce excessive hepatic fat production, reduce insulin resistance, inflammation and reactive oxygen species production, and improve liver fibrosis in a dose-dependent manner (NCT03938246)